4th Clinical Trials Nexus event

  • Europe
  • 17 October, 2019 09:00
  • 18 October, 2019 09:00

In 4th CTN you will gain insight into electronic solutions to aid slow recruitment in clinical trials. Moreover, 4th CTN will provide a right platform for a set of procedures in medical research and development that are conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g. drugs, diagnostics, therapy protocols)

Event Schedule
Event Speakers
Ticket Pricing
Day 1 : Timeline of Events
07:45 -08:45 Registration
08:45 - 09:00 Chair Person Welcome
09:00 - 09:30 Keynote 1
09:30 - 10:00 Keynote 2
10:00 - 11:40 Networking & Coffee Break
11:40 - 12:10 Keynote 3
12:10 - 12:40 Keynote 4
14:10-14:40 Keynote 5:
14:40-16:20 Networking & Coffee Break
16:20-16:50 Keynote 6
Key Note 7
Key Note 8
Key Note 9
Key Note 10
16:50 Conclusion
Day 2 : Timeline of Events
  • Associate Director, Country and Clinical Quality, Norgine
  • CEO, ImmuPharma plc
    Examining Outsourcing models in Clinical Trials: Challenges & Opportunities
  • CPM, Geropharm
    Patients in Clinical Trials: Recruitment in Clinical Trials of Biosimilars, sites & patient engagement
  • Clinical Innovations Leader, The Janssen Pharmaceutical Companies of Johnson & Johnson
    Smart Technologies to Transform Clinical Trials: From Concept to Implementation.
  • Corporate Vice President, Head of Cardiovascular & Metabolic Medicine, Boehringer Ingelheim
    Clinical trials of Cardiovascular Disorders Overcoming the Challenges in CVS & use of Biomakers in CVS
  • Innovation Lab Director, Roche
    Fully Electronic Clinical Trials: a new paradigm for Conducting Research AI Applications in Life Sciences & Healthcare
  • Clinical Development Physician, PhamaMar
  • Chief Medical Officer, Co-Founder ( Aurealis Therapeutics )
    Chief Medical Officer, Co-Founder
  • Medical Science Manager Oncology DACH bei Nanobiotix
    Medical Science Manager Oncology DACH bei Nanobiotix
  • CEO & Founder (SaySo)
    CEO & Founder at SaySo Medical
  • CEO & Founder (aPODD Foundation)
    CEO & Founder (aPODD Foundation)
  • Vice President international Medical Affairs, Vertex pharmaceuticals
    Developing an effective clinical outsourcing strategy: Analysing Risks and Benefits
  • CCO Therapeutic Area Leader Onco-Haematology, Roche
    Advancements in Oncology Trials, strategies for managing oncology trials
$0
Buy Ticket